DE2157148A1 - Immunisierungsmittel, verfahren zur herstellung und seine verwendung - Google Patents

Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Info

Publication number
DE2157148A1
DE2157148A1 DE2157148A DE2157148A DE2157148A1 DE 2157148 A1 DE2157148 A1 DE 2157148A1 DE 2157148 A DE2157148 A DE 2157148A DE 2157148 A DE2157148 A DE 2157148A DE 2157148 A1 DE2157148 A1 DE 2157148A1
Authority
DE
Germany
Prior art keywords
lipoid
bacteria
antibodies
antilipoid
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2157148A
Other languages
German (de)
English (en)
Inventor
Chris Galanos
Otto Dipl Chem Dr Luederitz
Otto Prof Dipl Chem Westphal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Original Assignee
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE791489D priority Critical patent/BE791489A/xx
Application filed by Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV filed Critical Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority to DE2157148A priority patent/DE2157148A1/de
Priority to CH1618372A priority patent/CH588867A5/xx
Priority to NL7215221A priority patent/NL7215221A/xx
Priority to SE7214629A priority patent/SE406419B/xx
Priority to GB5250272A priority patent/GB1416544A/en
Priority to DD166879A priority patent/DD102410A5/xx
Priority to AT975872A priority patent/AT332539B/de
Priority to FR7240734A priority patent/FR2160542B1/fr
Priority to JP11431772A priority patent/JPS5512002B2/ja
Priority to AU49027/72A priority patent/AU481470B2/en
Publication of DE2157148A1 publication Critical patent/DE2157148A1/de
Priority to AT775675A priority patent/AT332551B/de
Priority to US05/643,121 priority patent/US4029762A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2157148A 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung Ceased DE2157148A1 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BE791489D BE791489A (fr) 1971-11-17 Agent immunisant, procede de fabrication et utilisation d'un tel agent
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung
CH1618372A CH588867A5 (enExample) 1971-11-17 1972-11-07
NL7215221A NL7215221A (enExample) 1971-11-17 1972-11-10
SE7214629A SE406419B (sv) 1971-11-17 1972-11-10 Sett att framstella ett ympemne vari ingar lipoid a eller alkalibehandlad lipoid a
GB5250272A GB1416544A (en) 1971-11-17 1972-11-14 Immunizing agents for bacterial infections
DD166879A DD102410A5 (enExample) 1971-11-17 1972-11-15
AT975872A AT332539B (de) 1971-11-17 1972-11-16 Verfahren zur herstellung eines immunisierungsmittels
FR7240734A FR2160542B1 (enExample) 1971-11-17 1972-11-16
JP11431772A JPS5512002B2 (enExample) 1971-11-17 1972-11-16
AU49027/72A AU481470B2 (en) 1971-11-17 1972-11-17 Improvements in or relating to organic compounds
AT775675A AT332551B (de) 1971-11-17 1975-10-10 Verfahren zur herstellung eines antilipoid-a-serums
US05/643,121 US4029762A (en) 1971-11-17 1975-12-22 Lipid A-preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (1)

Publication Number Publication Date
DE2157148A1 true DE2157148A1 (de) 1973-05-24

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2157148A Ceased DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Country Status (10)

Country Link
JP (1) JPS5512002B2 (enExample)
AT (1) AT332539B (enExample)
BE (1) BE791489A (enExample)
CH (1) CH588867A5 (enExample)
DD (1) DD102410A5 (enExample)
DE (1) DE2157148A1 (enExample)
FR (1) FR2160542B1 (enExample)
GB (1) GB1416544A (enExample)
NL (1) NL7215221A (enExample)
SE (1) SE406419B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
WO2014097154A1 (en) * 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
AU4902772A (en) 1974-05-23
JPS5512002B2 (enExample) 1980-03-29
SE406419B (sv) 1979-02-12
FR2160542A1 (enExample) 1973-06-29
GB1416544A (en) 1975-12-03
ATA975872A (de) 1976-01-15
CH588867A5 (enExample) 1977-06-15
NL7215221A (enExample) 1973-05-21
AT332539B (de) 1976-10-11
BE791489A (fr) 1973-05-16
JPS4861621A (enExample) 1973-08-29
DD102410A5 (enExample) 1973-12-12
FR2160542B1 (enExample) 1976-04-23

Similar Documents

Publication Publication Date Title
DE69506212T2 (de) Impfstoff gegen gram-negative bakterielle infektionen
DE68928432T2 (de) Legionellosis-impfstoffe und verfahren zur herstellung
DE69518978T2 (de) Gruppe a streptokokkenpolysaccharide immunogen-zusammensetzungen und verfahren
DE69535374T2 (de) Aktive immunisierung gegen ein siderophores rezeptorprotein
DE69232585T2 (de) Oligosidderivat aus einem polyosidantigen von einem pathogenen erreger
DE2736223A1 (de) Allergen enthaltende substanzen, verfahren zu ihrer herstellung und ihre verwendung
EP0220387B1 (de) Konjugatimpfstoffe gegen Infektionen durch gramnegative Bakterien, Verfahren zu deren Herstellung sowie Verwendung derselben
DE69231663T2 (de) Polysaccharid-protein-konjugate
DE4447677C2 (de) Verfahren zur Herstellung eines Impfserums zur Immunisierung gegen Pseudomonas Aeruginosa-Infektionen
DE69330464T2 (de) Gruppe b streptococcus typ ii und typ v polysaccharid-protein konjugate als impfstoffe
DE2804457A1 (de) Immunsuppressive mittel
DE3882781T2 (de) Impfstoff gegen Pasteurella.
DE3587681T2 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
EP2497479A1 (de) Extrakte aus phototrophen Mikroorganismen als Adjuvans
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
DE2643641A1 (de) Antigene praeparate und verfahren zu ihrer herstellung
DE60216906T2 (de) Anti-pilyrosporum ovale igy und dessen verwendung
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE2704766A1 (de) Toxoid-impfstoff gegen pseudomonas aeruginosa-infektionen
DE1617545C2 (de) Verwendung von informatorischer Ribonucleinsäure als Vaccine
DE69231724T2 (de) Fischimpfstoff gegen infektion mit aeromonas salmonicida
DE1792256C3 (de) Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
DE2262427A1 (de) Immunostimulierendes mittel und verfahren zu dessen herstellung
DE2334376A1 (de) Immunologisches produkt, seine verwendung und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
OD Request for examination
8131 Rejection